Nicholas Company, Inc. Pacira Bio Sciences, Inc. Transaction History

Nicholas Company, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$25.5 - $31.51 $393,082 - $485,726	15,415 Added 9.99%	169,745 $4.86 Million
Q2 2023 Feb 13, 2024	SELL	$36.12 - $47.5 $2,528 - $3,325	-70 Reduced 0.05%	154,330 $6.18 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $47.5 $2,528 - $3,325	-70 Reduced 0.05%	154,330 $6.18 Million
Q1 2023 Feb 13, 2024	BUY	$35.53 - $43.38 $415,345 - $507,112	11,690 Added 8.19%	154,400 $6.3 Million
Q1 2023 May 11, 2023	BUY	$35.53 - $43.38 $415,345 - $507,112	11,690 Added 8.19%	154,400 $6.3 Million
Q2 2022 Feb 13, 2024	BUY	$51.49 - $81.64 $10,555 - $16,736	205 Added 0.14%	142,710 $8.32 Million
Q2 2022 Jul 26, 2022	BUY	$51.49 - $81.64 $10,555 - $16,736	205 Added 0.14%	142,710 $8.32 Million
Q1 2022 Feb 13, 2024	SELL	$60.03 - $76.49 $709,854 - $904,494	-11,825 Reduced 7.66%	142,505 $10.9 Million
Q4 2021 Feb 11, 2022	BUY	$47.97 - $62.21 $822,925 - $1.07 Million	17,155 Added 13.69%	142,505 $8.58 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $547,219 - $613,919	10,015 Added 8.68%	125,350 $7.02 Million
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $526,406 - $622,561	8,895 Added 8.36%	115,335 $7 Million
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $2,965 - $3,940	-50 Reduced 0.05%	106,440 $7.46 Million
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $5.37 Million - $7.06 Million	106,490 New	106,490 $6.37 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Nicholas Company, Inc. with notifications on news.